Veterinary drugs firm sees healthy increase in profits

Ian Page, chief executive, Dechra Pharmaceuticals
Veterinary products firm Dechra saw its underlying pre-tax profits increase by almost a quarter to £93.7m. The listed firm, which has its manufacturing base in Skipton, North Yorkshire, and its head office in Northwich, Cheshire, has this morning published its preliminary results for the year. For the year to 30 June 2018, Dechra reported revenue growth of 13.9% to £407.1m - up from £359m in the previous year. Underlying pre-tax profit increased by 23.6%, from £77m to £93.7m. Dechra is an international specialist veter... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...